Neuro News Roundup: Treating MS & Epilepsy
New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.
Early treatment of new onset multiple sclerosis (MS) with interferon β-1b therapy leads to clinical benefits. Several risk factors may help identify epilepsy patients who may be at higher risk for psychosis due to their antiepileptic drug treatment. Topiramate is an appropriate treatment for epilepsy patients with comorbid migraine.
Interesting Neuro: Treating MS & Epilepsy
Value of early MS treatment. Abstract link.
Early treatment of MS with interferon β-1b therapy can reduce the risk for conversion to clinically definite MS and decrease relapse rates.
Early MS treatment study results
Identifying anti-epilepsy drug-induced psychosis. Abstract link.
One in 7 cases of psychosis among epilepsy patients may be associated with anti-epilepsy drugs.
AED-induced psychosis study results
Topiramate for Epilepsy Patients with Migraine. Abstract link.
Topiramate is a reasonable first line option in newly diagnosed epilepsy patients who also have migraine headaches.
Take-home messages
Latest News
Unraveling the Roots of ALS Through Reactivation of HERVs and Antibody Levels
Virtual Reality Training May Improve Quality of Care in Lower Limb Spasticity With OnabotulinumtoxinA
Long-Term Safety of MS Treatment Ofatumumab Confirmed in ALITHIOS Extension
Tele-Yoga Breathing for Respiratory Function Proves Feasibility in Amyotrophic Lateral Sclerosis